+ Watch CTRX
on My Watchlist
The Company provides healthcare information technology solutions and pharmacy benefit management services to the pharmaceutical supply chain in the US and Canada.
Shares diluted for acquisitions and too expensive right now for thin margins. 2012 PEG 2.25. Forward (2013) PEG 1.29. Further dilution of thin margins by interest on LTDebt of 1.2B. See garifolle pitch on 14-Sept-12
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions